| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0079 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |